p53 and gene therapy for hepatocellular carcinoma

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 499-504

  Habib, Nagy A ^a   Mitry, Ragai R ^a   Sadri, Ramin ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; VIRUS PARTICLE;

EID: 0031723750     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_77     Document Type: Article

References (4)

1. Greenblatt,MS, Bebbett,WP, Hollstein,M and Harris,CC. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878.
2. Honda K, Sbisa E, Tullo A, Papeo PA, Saccone C, Poole S, Pignatelli M, Mitry RR, Ding S, Isla A, Davies A, Habib NA. (1997) p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br. J. Cancer [in press].
3. Habib NA, Ding S-F, El-Masry R, Mitry RR, Honda K and et al. (1996) Preliminary Report: The short-term effects of direct injection of p53 DNA injection in primary Hepatocellular Carcinoma. Cancer Detection and Prevention 20(2): 103-107.
4. Habib NA, Ding S-F, El-Masry R, Dalla Serra G, Izzi G and et al. (1995) Contrasting effects of direct p53 DNA injection in primary and secondary liver tumors. Tumor Targeting 1: 295-298.